農本方®藥用雲芝乃採用一級天然野生雲芝,按GMP標準精製而成,乃藥用級雲芝產品,雲芝純度極高,能強化身體之免疫功能,對初期、中期及末期患者的體質均有明顯改善,是多數患病必備的食療配方。每粒含400毫克藥用雲芝精華,每瓶相等於3.0克天然野生雲芝。
雲芝自古至今一直被用作增強抵抗力、強壯身體機能及對抗嚴重疾病的療劑。近年的科學研究及臨床實驗亦証實雲芝能強化病者的免疫能力,有助身體對抗嚴重疾病。
- 活化免疫細胞,如T-淋巴細胞、B-淋巴細胞、單核白血球、巨噬細胞、自然殺傷性細胞和淋巴因子活化殺手細胞等1,2,3。
- 增加抗體及多種細胞因子,包括白細胞介素-2、白細胞介素-6、干擾素和異常細胞壞死因子2,4。
- 回復因頑疾或因療程而降低的免疫反應至正常水平2,3。
- 提升人體的抵抗力5,6,減少各種感染的機會2,4。
- 減輕頑疾治療的副作用,改善病患者的精神及健康狀況7。
- 抑制異常細胞增生5,8。
- 提高頑疾病患者的存活率5,9,10,11
農本方® 藥用雲芝臨床用法及用量
1)接受化療 ,放療或於手術前 |
|
於十四天前開始服用,每日兩次,每次兩粒,或遵照醫師指示服用。 |
2)接受化療,放療或手術後 |
|
每日服用兩次,每次兩粒,連續服用六個月,或遵照醫師指示服用。 |
3)無法接受化療, 放療或手術的病人 |
|
每日服用兩次,每次四粒,連續服用六個月後,可視乎病情進展酌量增減,或遵照醫師指示服用。 |
|
農本方® 藥用雲芝產品資料
成份 : 100%純天然野生雲芝
包裝 :
360粒瓶裝
每瓶360粒膠囊 , 每粒含400亳克
藥用雲芝精華 , 每瓶相等於
1,080克天然野生雲芝
儲存 : 置於陰涼乾燥處
|
Reference:
- Chu K.K.W., Chow A.H.L. (2006) Preparation and standardization of immunomodulatory pepdite-linked glucans with verifiable oral absorbability from coriolus versicolor. United States patent filling: US 7,048,932 B2
- Chu K.K.W., Ho S.S.S., Chow A.H.L. (2002) Coriolus versicolor: a medical mushroom with promising immunotherapeutic values. J Clin Pharmacol, 42(9):976-84
- Liu F., Ooi V.E.C, Fung M.C. (1999) Analysis of immunomodulating cytokines mRNAs in the mouse induced by mushroom polysaccharides. Life Sci. 64(12):1005-11
- Tsukagoshi S., Hashimoto Y., Fugii G., Kabayashi H., Namoto K., Orita K. (1984) Krestin (PSK). Cancer Treatment Rev. 11:131-55
- King-Fai Cheng, Ping-Chung Leung (2008) General review of polysaccharopeptides (PSP) from c.versicolor: pharmacological and clinical studies. Cancer Therapy Vol.6:117-30
- Leung M.Y. K., Liu C., Koon J.C.M., Fung K.P. (2006) Polysaccharide biological response modifiers. Immunology Letters 105:104-14
- Zhong Y., Zou J., Zhang L.Y. (2001) Clinical observation on alleviating chemotherapy’s side effect of PSP in treating gastric carcinoma. Liaoning Journal of Traditional Chinese Medicine 28:668-9
- Zhou Y.L., Hua J., Lin J., Tang K.X. (2007) Cytotoxic activities of coriolous versicolor (Yunzhi) extracts on human liver cancer and breast cancer cell line. Afr J. Biotechnol 6:1740-43
- Ohwada S., Ogawa T., Makita., Tanahashi F., Ohya T., Tomizawa N., Satoh Y., Kobayashi I., Izumi M., Takeyoshi I., Hamada K., Minagushi S., Togo Y., Toshihiko T., Koyama T., Kamio M (2006) Beneficial effects of potein-bound polysaccharide K. plus tegafur/uracil in patients with stage II or III colorectal cancer: analysis of immunological parameters. Oncology Reports 15:861-8
- Wong L.Y. Eliza, Cheng K.F., Leung P.C. (2012) Efficacy of yunzhi (coriolus versicolor) on survival in cancer patients: systematic review and meta-analysis. Recent Patents on Inflammation & Allergy Drug Discovery 6:78-87
- Yamashita K., Ougolkov A.V., Nakazato H., Ito K., Ohashi Y., Kitakata H., Yasumoto K., Omote K., Mai M., Takahashi Y., Minamoto T. (2007) Adjuvant immunochemotherapy with protein-bound polysaccharide K for colon cancer in relation to oncogenic beta-catenin activation. Dis Colon Rectum 50:1169-81